Followers | 611 |
Posts | 26764 |
Boards Moderated | 1 |
Alias Born | 08/12/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 18, 2018 10:27:53 AM
Whether it represents a growing share price .20-.50+ or a buyout over $1. It benefits CMH to get notes cleaned up.
Patented advanced IP Technology targeting BILLIONS in revenue. Pushing 100 BILLION to be exact and much of those BILLIONS are recurring annual revenues!!!
Clean Up has been underway of debt and Notes!!! GOOD ANYWAY YOU LOOK AT IT.
CMH needs to get that debt converted to shares prior to a buyout. Restricted keeps the investors happy maintaining a low float and keeps the PPS going UP.
Which helps in negotiating a price somewhat however we are a market cap play!!!
If the debt doesn't get converted I bet it gets real complicated and paid on a cash basis in a post sale situation. They then will NOT get the premium they will get when they are converted to shares prior to the BUY OUT for a PPS in the $$$!!! I hope this makes sense to everybody including the newbies. I could show an example whereby debt is paid after buy out versus debt convert to shares at .0138 and later getting $1 per share. Huge premium by converting to shares first. The 9 million shares instead of being paid $125,000 they would receive 9 million dollars. That reflects debt of $125,000 being converted to 9 million shares at .0138. The 9 million dollars reflects a purchase price of 500 million dollars considering 500 million O/S supports a $1 PPS buyout price. 9 million shares multiplied by $1 = 9 million in cold hard cash.
Believe this, the company will not be sold for less than 500 million. Bet on it!!!!
The Second Generation stem cell technology is huge. Stem cells using embryo's creates way to much controversy. Stem cells from coord blood leaves 99% of the public out of luck. The 2nd generation technology letting you use your own current stem cells is REVOLUTIONARY TO SAY THE LEAST. FOLKS ARE NOT GETTING THE REAL PLAY HERE. ITS THE TECHNOLOGY.
The "ED" Procedure gives an incredible revenue generator to start with but the REAL PLAY IS THE PATENTED TECHNOLOGY!!!! NO LESS THAN 500 MILLION!!!!
$CELZ
ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM